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nabhan@hotmail.com (B. Padmanabhan).The BET family proteins recognize acetylated chromatin through their two bromodomains, acting as
transcriptional activators or tethering viral genomes to the mitotic chromosomes of their host. The
structural mechanism for how the N-terminal bromodomain of human BRD2 (BRD2-BD1) deciphers
the mono-acetylated status of histone H4 tail was recently reported. Here we show the crystal struc-
ture of the second bromodomain of BRD2 (BRD2-BD2) in complex with the di-acetylated histone H4
tail (H4K5ac/K12ac). To our surprise, a single K5ac/K12ac peptide interacts with two BRD2-BD2 mol-
ecules simultaneously: the K5ac residue binds to one BRD2-BD2 molecule while the K12ac residue
binds to another. These results provide a structural basis for the recognition of two different pat-
terns of the histone acetylation status by a single bromodomain.
Structured summary:
MINT-7989882, MINT-7989824, MINT-7989846, MINT-7989865: H4 (uniprotkb:P62805) binds (MI:0407)
to BRD2 (uniprotkb:P25440) by surface plasmon resonance (MI:0107)
MINT-7989539: H4 (uniprotkb:P62805) and BRD2 (uniprotkb:P25440) bind (MI:0407) by X-ray crystallog-
raphy (MI:0114)
 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The histone code, deﬁned by combinatorial modiﬁcations of the
ﬂanking histone tails, represents eukaryotic regulatory mecha-
nisms of DNA-mediated events through structural alteration of
the chromatin and/or association of trans-acting factors onto it
[1]. Among known modiﬁcations of the core histones, acetylation
of the histone tails and its recognition is a typical hallmark for
transcriptional activation from chromatin DNA [2]. The acetylated
N-terminal tails of the histones are speciﬁcally recognized by a
bromodomain which is a conserved structural domain composed
of approximately 110 amino acids [3]. The bromodomain is present
in many chromatin-associated factors, including nuclear histone
acetyltransferases (HATs), chromatin-remodeling factors, and thechemical Societies. Published by E
ctural Biology Center, 1-7-22
, Aptuit Laurus Pvt. Ltd., ICICI
500078, India. Fax: +91 40
.jp (S. Yokoyama), bpadma-bromodomains and extra-terminal domain (BET) family of nuclear
proteins [3,4].
The BET family of nuclear proteins has the unique architecture
with two tandem bromodomains and a conserved extra-terminal
domain [3–6]. Through its bromodomains, the BET protein BRD2
selectively recognizes the acetylated lysine 12 (K12) of histone
H4 for transcriptional activation [7], while another BET protein
BRDT most prefers to recognize the K5/K8-di-acetylated histone
H4 [8]. In human cells, BRD2- and BRD3-associated chromatin is
signiﬁcantly enriched in K5- and K12-acetylated histone H4 [9].
Importantly, the BET proteins BRD2 and BRD4 associate with
acetylated chromatin throughout the cell cycle [7,10], while other
non-BET bromodomain family members dissociate from the chro-
mosomes during mitosis [11]. This mitotic retention on chromo-
somes is the unique feature of the BET proteins, which can be
utilized by papilloma virus, and also presumably by Kaposi’s sar-
coma-associated herpesvirus, for tethering their genomes to the
mitotic chromosome of their host, and for propagating them
during the cell division [12,13]. Recently, structural basis of the
recognition of K5/K8-di-acetylated histone H4 tail by the N-termi-
nal bromodomain of BRDT was reported, in which both thelsevier B.V. All rights reserved.
Table 1
Summary of data collection and reﬁnement statistics.
BRD2-BD2 + H4K5ac/K12ac
Data collection
Wavelength (Å) 1.0
Space group P21
Unit cell (Å, ) a = 45.83, b = 128.59, c = 45.85, b = 104.7
Resolution (Å) 50–2.30 (2.38–2.30)
Redundancya 3.7 (3.7)
Unique reﬂections 22 434
Completeness (%) 97.7 (97.9)
Rmerge (%)b 4.8 (16.6)
Reﬁnement statistics
Resolution (Å) 20–2.30
r cutoff 0
Reﬂections 21 151
No. protein residues 847
No. peptide residues 28
No. water molecules 412
Rcryst (%)c 20.4
Rfree (%)d 26.8
Average B factors 43.69
R.m.s deviations
Bond lengths (Å) 0.023
Bond angles () 1.87
a Numbers in parentheses are values in the highest resolution shell.
b Rmerge = R |Iobs  <I>|/R <I> summed over all observations and reﬂections.
c Rcryst = R ||Fobs|  |Fcalc||/R |Fobs|.
d Rfree was calculated with 5% of data omitted from reﬁnement.
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omain [14]. We reported the structural basis for the N-terminal
bromodomain of BRD2, BRD2-BD1, to decipher the histone code
by means of recognizing K12-acetylated histone H4 tail [15,16].
However, structural basis how the second C-terminal bromodo-
main of BET family proteins recognize an acetylation status of his-
tone H4 has been unclear, except a few NMR analyses [17,18].
To further gain insight into the structural basis for the recogni-
tion of the BET bromodomains and acetylated histone H4, we
determined the crystal structure of the second C-terminal bromod-
omain of BRD2, BRD2-BD2, in complex with a histone H4 tail pep-
tide which is di-acetylated at K5 and K12 (H4K5ac/K12ac).
Surprisingly, the K5/K12-di-acetylated H4 tail peptide interacted
with two BRD2-BD2 molecules simultaneously. Based on the struc-
tural and biochemical analyses, we discuss a possible role of the
second bromodomain of BRD2 for recognition of active chromatin
containing K5- and K12-acetylated histone H4.
2. Materials and methods
2.1. Peptides and proteins
The K5/K12-di-acetylated histone H4 tail peptide (residues 1-
15; SGRGK(Ac)GGKGLGK(Ac)GGA) used for the crystal structure
analysis, and relevant histone tail peptides, H4 (1–20) and H3
(10–27), biotinylated at C-termini used for the binding analysis,
were purchased from Toray Research Center (Kamakura, Japan).
Expression and puriﬁcation of the BRD2-BD2 protein were per-
formed as described elsewhere [19].
2.2. Crystallization and data collection
The BRD2-BD2 protein in complex with the di-acetylated his-
tone H4 tail peptide was crystallized by co-crystallization method,
by mixing the peptide and protein solutions (10:1 molar ratio) and
incubating them at 4 C for about 4 h before setting up the crystal-
lization experiment. The crystals were obtained from 30% PEG
MME 2000 and 50 mM Tris–HCl, pH 8.0, as thin plates of 20–
30 lm thick. These crystals belong to P21 space group and contain-
ing four BD2 molecules and two peptides in an asymmetric unit. A
complete dataset up to 2.30 Å resolution was collected at the
beamline AR-NW12A, Photon Factory, Japan, and processed and
scaled using the HKL2000 program suite [20].
2.3. Structure determination and reﬁnement
The crystal structure of the BRD2-BD2 protein in complex with
the di-acetylated histone H4 tail peptide was solved by the molec-
ular replacement method, using the BRD2-BD1 structure [15] as a
model, with the MOLREP program incorporated in CCP4. The pro-
tein chains were ﬁtted manually using the graphics program O
[21]. The model was reﬁned with CNS [22], using a maximum like-
lihood target that included amplitude and phase probability distri-
butions. NCS restraints (200 kcal mol1 Å2) were maintained
between the NCS molecules throughout the reﬁnement. During
the course of ﬁtting, rA-weighted electron density maps clearly re-
vealed the electron density for the acetylated histone H4 tail pep-
tides. The program REFMAC5 from the CCP4 suite [23] was used
in the ﬁnal steps of reﬁnement. With the NCS restraints which were
imposed throughout the reﬁnement, the ﬁnal complete structure at
2.30 Å resolution consists of 847 protein residues, 28 peptide resi-
dues, 412watermolecules, gave a ﬁnal R-factor of 20.4% and an Rfree
of 26.8%. The stereochemistry of the protein chains is good, as as-
sessed with PROCHECK [24]. Reﬁnement statistics are summarized
in Table 1. Atomic coordinates and structure factors have been
deposited in the Protein Data Bank. The PDB ID is 2E3K.2.4. Surface plasmon resonance binding assays
The binding afﬁnities of the BRD2-BD2 proteins against the H4
or H3 tail peptides were examined on a Biacore 3000 (GE Health-
care) with PBS (pH 7.4) as the running buffer. Biotinylated H4 tail
peptides, corresponding to the N-terminal region from 1 to 20 of
histone H4, or biotinylated H3 tail peptides, corresponding to the
region from 10 to 27 of histone H3, were immobilized on ﬂow cells
#2–#4 of a sensor chip SA (GE Healthcare). Amounts of the immo-
bilized peptides were within the range of 650–930 resonance units,
and the binding of the BRD2-BD2 protein to each peptide-immobi-
lized sensor chip was normalized to each theoretical maximal res-
onance unit (Rmax). Control surfaces with d-biotin attached were
used to correct for refractive index differences between the sam-
ples and the running buffer. Dissociation constants (KD) for the
interaction were calculated with the steady-state afﬁnity model
of the BIAevaluation 4.1 software (GE Healthcare).
3. Results and discussion
3.1. Overall structure of BRD2-BD2 in complex with the K5/K12-di-
acetylated H4 tail
We solved the crystal structure of the second bromodomain of
human BRD2 (BRD2-BD2: residues 348–455; Fig. 1A and B) in com-
plex with a histone H4 tail peptide (residues 1–15) which is di-
acetylated at K5 and at K12. The crystals are of P21 space group,
with four bromodomain molecules, and two peptides in an asym-
metric unit (Fig. 1C). The BRD2-BD2 structure contains a left-
handed a-helical bundle formed by four a-helices (i.e. aZ, aA, aB,
and aC) (Fig. 1B), which is similar to the solution structures of
BRD2-BD2 [17] and BRD4-BD2 [18], crystal structures of BRD2-
BD1 [15,16], BRDT-BD1/BD2 [14], and other bromodomain struc-
tures [25–30]. An extended long loop, ZA, connecting the helices
aZ and aA, and another loop, BC, connecting the helices aB and
aC make a deep cleft with a cavity in the middle of the pocket,
which deﬁnes the binding site for acetylated histone tail (Fig. 1B
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Fig. 1. BRD2-BD2 interaction with acetylated histone H4 tails. (A) Schematic representations of the BRD proteins. The bromodomains (BD1 and BD2) and the extra-terminal
domain (ET) are indicated by blue and green boxes, respectively. Two other conserved regions are shown as black and gray boxes. (B) A ribbon diagram of the BRD2-BD2
structure, colored from blue (N-terminus) to red (C-terminus). (C) Stereo-view of the BRD2-BD2 complex. The BRD2-BD2 and H4K5ac/K12ac tail peptides are shown by ribbon
models, and the side-chains of H4K5ac and H4K12ac are indicated by stick models. The color codes for the BRD2-BD2 dimers and the H4 tails are consistent in all ﬁgures
unless otherwise stated. All structure ﬁgures were generated with Pymol (http://www.pymol.org/).
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the conserved hydrophobic residues, and additionally, by some
conserved hydrophilic residues.
The reﬁned structure showed that BRD2-BD2 formed two homo-
dimers in the asymmetric unit. In the crystal, the weak dimeric
interface arises from the helices aB and aC (Fig. S1). In this weak
dimeric interface, no direct intermolecular interactions have been
observedbut throughburiedwatermolecules. Our in vivo co-immu-
noprecipitation studies did not show any self-association between
the BD2 molecules (data not shown), and the NMR study reported
by Shi andher colleagues also suggests that BRD2-BD2 is amonomer
in solution [17]. In addition, although the crystal structure of BRDT-
BD2 possesses similar NCS arrangement in the asymmetric unit,
BRDT-BD2 is a monomer in solution [14]. Taken together, we con-
sider that BRD2-BD2 may also be a monomer in solution.3.2. Recognition of the K5/K12-di-acetylated histone H4 tail by BRD2-
BD2
The crystal structure analysis clearly showed that the di-acety-
lated H4 tail peptide bound to BRD2-BD2. The difference Fourier
map unambiguously detected the electron density for the acety-
lated H4 tail peptide in the cleft region of the BD2 protein
(Fig. S2A and B). We observed several noteworthy features from
this structural analysis: First, the BRD2-BD2 protein recognized
acetyl-lysine 5 (K5ac) as well as acetyl-lysine 12 (K12ac) of the
H4 tail peptide. Second, besides its recognition for the acetyl-lysine
at different positions, it recognized them simultaneously through
different BRD2-BD2 molecules. Third, extensive interactions were
observed between the BRD2-BD2 protein and many residues of
the H4 tail peptide (described below).
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BD2
In the structure of the complex, the H4 peptide Q binds into the
long cleft region, which is produced by the monomers A1 and A2 of
A1B1 and A2B2, respectively, with a non-speciﬁc extended confor-
mation (Fig. 1C). The side-chain of K5ac sits in the deep hydropho-
bic pocket of the molecule A1, formed by the residues P371, F372,
V376, L381, L383, C425, and V435 (Fig. 2A). The acetyl group of
K5ac is positioned in the cavity in such a way that the carbonyl
group is hydrogen bonded to the Nd2 of N429, as well as indirectly
to the side-chain of Y386 through a water molecule (Fig. 2A),
which is essentially conserved in other bromodomain structures
[3,5]. A hydrogen bond network between the water molecules ex-
ists on one side of the K5ac side-chain. The side-chain atom Nf of
K5ac forms a water-mediated hydrogen bond with the carbonyl
group of P371. Similar modes of interactions are also observed
for the side-chain K12ac, which binds to the monomer A2
(Fig. 2B). The charge distribution on the cavity surface is comple-
mentary to the aliphatic moiety (Fig. S3).
The di-acetylated H4 tail peptide extensively interacts with its
protein partners, A1 and A2 molecules, as well as with many water
molecules (Fig. 2C, D and S2A). The ﬁrst 8 residues of the peptide
associate with the chain A1, and the residues from 9 to 15 interact
with A2 of the A2B2 chains (Fig. S2A). The main-chain carbonyl
group of G2 possesses a bifurcated hydrogen bond interaction with
the atoms Od1 and Od2 of D385 (Fig. 2C). The backbone carbonyl
group of R3 contributes a main-chain-main-chain interaction with
Y428, and also forms a hydrogen bond with a water molecule. Nev-
ertheless, the guanidyl group of R3 (the NH1 atom) contributes a
substantial interaction with Ne2 of H433 (Fig. 2C). A hydrogen
bond is formed between the carbonyl group of the residue, G4,
and the hydroxyl group of Y428. In addition, carbonyl–carbonyl
dipolar interaction is also observed between G4 and Y428
(Fig. 2C). Although the residue G6 does not have any electrostatic
interaction with the protein atoms, it forms hydrogen bond inter-
actions with water molecules. For G7, the backbone amide group
exhibits a weak interaction with the Nd1 atom of H433, however,
the main-chain amino group of D434 contributes a hydrogen bond
to its carbonyl group. A salt link is also observed between K8 and
the residue D432.
The backbone amide and carbonyl groups of G9 are hydrogen
bonded to the carbonyl group of D432 of the molecule A1, and
the main-chain amide group of D434 of the molecule A2, respec-
tively (Fig. 2C). Moreover, it also electrostatically interacts with
two water molecules. The ﬂexible residues G11 and G13 make
electrostatic interactions with Nd1 of H433 and Od1 of N429 in
the molecule A2 (Fig. 2D). The mode of side-chain interaction of
K12ac is well conserved with that of K5ac. The last amino acid,
A15, of the H4 tail peptide is hydrogen bonded to the main-chain
nitrogen atom of P430.
3.4. Interaction of the second di-acetylated H4 peptide chain R with
BRD2-BD2
The electron density for the H4 peptide chain R was also clearly
visible, except for the ﬁrst two residues, S1 and G2, and for the
side-chain of R3 (Fig. S2B). This H4 peptide interacts with B2 of
A2B2 and B3 of the symmetry-related A3B3 (A10B10) molecules
(Fig. 2E). G4 hydrophobically interacts with Y428 and P430 of the
B2 molecule. The main-chain nitrogen atom of K5ac makes a
hydrogen bond interaction with the side-chain atom, Od1 of
N429. The interaction for K5ac side-chain atoms with the BD2 pro-
tein are well maintained as found in the peptide chain Q. The next
residue, G6, forms a hydrogen bond to Ne2 of H433. In addition to
contributing the electrostatic interaction with water molecule, K8also makes hydrogen bonds with the residues G382 and H384 in
the molecule A3. The carbonyl group of K12ac makes contact with
H433. Furthermore, G13 and G14 sit in the hydrophobic pocket
created by the residues, W370 and Y373.
Interestingly, the peptide chain Q has more interactions with
BRD2-BD2 residues than the interactions observed in the peptide
chain R. In the complex with the peptide Q, the axis of the helical
bundle of the bromodomain A2 is approximately 120 with respect
to that of the bromodomain A1, and the arrangement of orientation
makes in such a way that the peptide-binding sites of the bromod-
omain A1 and A2 are close together. Whereas in the peptide R com-
plex case, the binding sites of the bromodomain B2 and B3
(symmetry molecule, B10) are relatively wide apart as well as the
helical bundle axes are nearly perpendicular to each other. When
measured the distances between Ca of K5ac and K12ac, we ob-
served the corresponding distances of 16.27 and 19.41 Å in the
chains Q and R, respectively. In both the Q and R chains, the back-
bone torsion angles (/, w) at K5ac and K12ac are approximately
(110, 5) and (90, 120), respectively, which correspond to
the b-strand region of the Ramachandran plot. The two peptides
possess non-speciﬁc ﬂexible secondary structures which appeared
mainly due to the presence of many glycine residues in the pep-
tide, particularly, the peptide R maintain nearly fully extended
conformation compared to the chain Q (Fig. S4). The extensive
interactions with the K12/K5-di-acetylated histone H4 tail, as ob-
served in the present study, may help BRD2 associate with mitotic
chromosomes [7,10].
3.5. Binding analysis of BRD2-BD2 and acetylated histone tail peptides
The N429A (N382A in the reference 17) mutation reportedly re-
duces the binding afﬁnity with the K12-acetylated H4 peptide, and
L381A (L334A) and L383A (L336A) mutants also moderately affect
the binding efﬁciency with the acetylated H4 peptide in NMR titra-
tion studies [17]. From our present study, it is clear that N429
interacts with K12- and K5-acetylated H4 tail peptide. Besides,
the region from L381–H384 clasps the acetylated H4 tail peptide
on one side of the peptide-binding cleft region (Fig. 2A and B).
The corresponding bromodomain in BRD4, BRD4-BD2, also recog-
nizes the H4 tail di-acetylated at K5 and K12 [10,18]. Remarkably,
the highly conserved residues D385, Y429, N429, D432 and H433
of BRD2-BD2, which are directly interacting with the H4 peptide
chain, markedly affect the binding efﬁciency for the H4K5ac/
K12ac peptide in solution [17].
We examined interaction between BRD2-BD2 and histone H4
tail peptide in solution by surface plasmon resonance (SPR) analy-
sis. BRD2-BD2 bound to K5-, K8-, or K12-acetylated H4 tail peptide
at almost similar afﬁnities (Fig. 3A). The KD values of the SPR inter-
actions, which were estimated from the range of the protein con-
centration from 0 to 320 lM, are approximately 180, 280, and
300 lM to the K5-, K8-, and K12-acetylated H4 tail peptides,
respectively. On the contrary, the BRD2-BD2 did not bind to the
K16-acetylated H4 tail peptide (Fig. 3A). Huang et al. reported that
BRD2-BD2 binds H4K12ac with a KD of 2.9 mM in their NMR titra-
tion analysis [17], which is much weaker than our observed data.
This discrepancy is presumably due to the difference of the meth-
ods analyzed in both studies. When we examined the interaction
between BRD2-BD2 and the K5/K12-di-acetylated H4 tail peptide,
we observed almost as twice-efﬁcient binding as compared to
the mono-acetylated H4 tails (Fig. 3A). The KD value of this interac-
tion to the di-acetylated H4 peptide was estimated to be approxi-
mately 140 lM, suggesting that two molecules of BRD2-BD2 may
simultaneously bind to one molecule of the immobilized K5/K12-
di-acetylated H4 tail peptide, with least cooperativity. These re-
sults reveal that BRD2-BD2 binds to the histone H4 tail through
the acetylated lysine at K5, K8 or K12, but not through K16. As
Fig. 2. The BRD2-BD2 dimers interact with di-acetylated H4 tails, Q and R. (A) A representative cartoon diagram of K5ac binding region. (B) A representative cartoon diagram
of K12ac binding region. The acetyl-lysine binding interaction is very similar both in K5ac and K12ac. (C) A close-up view (in stereo) of the H4 tail Q near the K5ac binding
region. (D) A close-up view (in stereo) of the H4 tail Q near the K12ac binding region. (E) A close-up view (in stereo) of the H4 tail, R interaction with BD2. The interacting
residues and water molecules in (A–E), are shown by sticks and balls, respectively.
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known manner, further structural studies will be required to
understand how BRD2-BD2 recognizes H4K8ac. We also examined
interaction between BRD2-BD2 and histone H3 tail peptides.
Intriguingly, BRD2-BD2 substantially bound to the K18-acetylatedhistone H3 tail peptide (residues 10–27), while it did not bind to
the H3K23ac peptide (Fig. 3B). The estimated KD value of 180 lM
observed for the BRD2-BD2 – H3K18ac interaction is similar to
the value of 251 lM observed for the binding of BRDT-BD2 to
H3K18ac by isothermal titration calorimetry [14]. Taken together,
Fig. 3. Surface plasmon resonance binding analysis of BRD2-BD2 and the acetylated
histone tails. (A) Binding analysis between BRD2-BD2 and histone H4 tails. Dose-
dependent binding results ranging from 0 to 320 lM of the protein concentration
were shown. The binding activity to the BRD2-BD2 protein was compared between
the hypoacetylated (open circle), K5-acetylated (open square), K8-acetylated (open
triangle), K12-acetylated (ﬁlled circle), K16-acetylated (ﬁlled square), and K5/K12-
di-acetylated (ﬁlled triangle) histone H4 tail peptides (residues 1–20). Binding score
was evaluated regarding the theoretical maximal resonance unit (Rmax) of the each
peptide as 100%. (B) Binding analysis between BRD2-BD2 and histone H3 tails. The
binding activity to the BRD2-BD2 protein was compared between the hypoacety-
lated (ﬁlled circle), K18-acetylated (ﬁlled square), and K23-acetylated (open
triangle) histone H3 tail peptides (residues 10–27).
3906 T. Umehara et al. / FEBS Letters 584 (2010) 3901–3908these results indicate the preferential binding of BRD2-BD2 to the
K18-acetylated H3 tail as well as to the K5/8/12-acetylated H4
tails.
3.6. Structural comparison with BRDT-BD2
Recently, the crystal structures of BD1 and BD2 of mouse BRDT
(mBRDT) were reported [14]. The overall structure of BRDT-BD2 is
almost identical to that of BRD2-BD2. Superposition of the mole-
cule A of BRDT-BD2 onto the molecule A of BRD2-BD2 gave r.m.s.
deviation of 0.5 Å for all Ca atoms (Fig. 4A). Intriguingly, the
oligomer formation in BRDT-BD2 is identical to that found in the
BRD2-BD2 structure (Fig. 4A). BRDT-BD2 recognizes histone H3 tail
acetylated at K18 (H3K18ac) [14]. We observed that the amino
acids and structures in the binding sites of both BD2 bromodo-
mains are almost conserved and identical (Fig. 4B and S5), imply-ing that BRDT-BD2 may also recognize K5ac and/or K12ac of the
histone H4 tail. Conversely, BRD2-BD2 recognized H3K18ac as
demonstrated in Fig. 3B. When we compared H3K18ac and
H4K5ac/K12ac peptides in the structures of respective complexes,
R17 of histone H3 and R3 of histone H4 are located at equivalent
positions pointing towards the conserved residues, D354 and
H355 (in mBRDT-BD2), and D432 and H433 (in BRD2-BD2), respec-
tively. Hence the two residues, H3-R17 and H4-R3, may play criti-
cal roles for speciﬁc recognition of the acetylated histone tails by
BRDT-BD2 and BRD2-BD2.3.7. Structural comparison with other bromodomains
The left-handed four-helical domain of the BRD2-BD2 protein is
conserved in the bromodomain family [25–30]. The overall struc-
tures of these bromodomains are similar; however, the acetylated
histone H4 tail-binding site possesses major structural variations,
particularly in the ZA and BC loop regions (data not shown). Re-
cently we reported the structural basis of BRD2-BD1 for the recog-
nition of K12-acetylated H4 tail [16]. When we superposed the
BRD2-BD2 complex with the BRD2-BD1 complex for main-chain
atoms of the bromodomains, the overall structures of the BD1
and BD2 are nearly similar to each other (average r.m.s. deviation
value of 1.0 Å). However, an intriguing feature is observed when
analyzed the peptide-binding regions of BD1 and BD2 by superim-
posing the histone H4 tail peptides with respect to their acetyl-ly-
sines. In the case of BD2 recognition for K5ac, the peptide runs
from N- to C-terminal direction with respect to the ZA loop of
the bromodomain in one monomer (Fig. S6A) whereas it runs in
the opposite direction for K12ac interaction with respect to ZA loop
in another monomer (Fig. S6B). It suggests that BRD2-BD2 recog-
nizes the peptide direction depending upon the interaction of
K5ac and K12ac. It is interesting to note that the peptide direction
in the BD1 complex is opposite to that found in the BD2 complex,
with respect to K12ac position (Fig. S6B), suggesting that, for the
K12ac binding, the BD1 and BD2 bromodomains recognize the
H4 peptide in different manner.
Sequence comparison between BRD2-BD1 and BRD2-BD2
shows approximately 44% of sequence identity between them
(Fig. S5). The BD2 bromodomain interacts with the H4 peptide
through the residues from the ZA and BC loops, but in the BD1
complex, the interaction occurred through the residues mainly
from the BC loop. The residues in the vicinity of the acetyl-lysine
binding region are highly conserved; however, some non-con-
served residues are observed in the peptide-binding regions, for
example, H433/D160, P430/K157, and H384/P111 (Fig. S5). Thus,
signiﬁcant numbers of non-conserved residues which are responsi-
ble for the peptide interaction are the key components for discrim-
inating acetylated H4 tail recognition between BD1 and BD2 in
different manner.
Sequence comparisons from BRD2 and BRD4 indicate that the
corresponding bromodomains (i.e. BRD2-BD1 vs BRD4-BD1;
BRD2-BD2 vs BRD4-BD2) are highly homologous (75% sequence
identity) as compared to the non-equivalent bromodomains, BD1
vs BD2 (Fig. S5). The H4 tail-interacting residues are highly con-
served between the equivalent bromodomains, suggesting that
the structures of BRD4-BD1 and BRD4-BD2 are similar to that of
BRD2-BD1 and BRD2-BD2, respectively.
Our present study and previous reports [15,16] indicated that
the BRD2-BD1 and -BD2 bromodomains both recognize K12ac
and K5ac of histone H4. However, further structural and biophysi-
cal studies on how the tandem BET bromodomains, BD1 and BD2,
simultaneously recognize multi-acetylated histone tails will aid
understanding of the mechanism for deciphering and protecting
the acetylation histone code on the chromatin.
Fig. 4. Comparison between BRD2-BD2 and mBRDT-BD2 complexes. (A) Stereo-view of the superposition of the BRD2-BD2 chains (colored in green and yellow) on to the
mBRDT-BD2 chains (colored in gray) over Ca-atoms corresponding to the equivalent structured regions. The H3 and H4 tail peptides are colored in blue and orange,
respectively. (B) A close-up stereo-view near the acetyl-lysine binding regions. The residues, Arg3 of histone H4 and Arg17 of histone H3 (shown by sticks) are located at
equivalent position in the respective complexes. The conserved residues of the respective BD2 molecules, responsible for the peptide interactions are shown by sticks.
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